FDA Inspection 1283114 - Solaris Pharma Corp - September 18, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Solaris Pharma Corp, with an inspection on September 18, 2025, issued by the New Jersey District Office, covering human drugs.

Company: Solaris Pharma Corp
Inspection Date: September 18, 2025
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · 21c2d32d-4377-4be5-8382-b321a855a9ae

Violation Codes1

21 CFR 314.80(c)(2)

Full citation text and observation details available on the Dashboard.